$MOVE Cashflow Statement | Understand Stock

$MOVE

$7.37 +$0.30 (4.17%) Live

$MOVE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
Depreciation
Forgiveness of Paycheck Protection Program loan
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Stock-based compensation
Accretion of debt discount on convertible promissory notes
Noncash lease expense
Accretion of discount on short-term investments
Write-down of inventory to net realizable value
Amortization of debt discount (related party)
Accrued interest on convertible promissory notes
Non-employee services under convertible promissory notes
Compensation of non-employee services upon issuance of common stock
Change in fair value of derivative liability
Interest expense on bridge loan (related party)
Non-cash compensation related to common stock warrants issued to strategic advisory group
Loss on disposal of property and equipment
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Payroll tax credit
Inventory
Prepaid expenses, vendor deposits and other current assets
Other assets
Accounts payable
Deferred revenue
Other current and noncurrent liabilities
Net cash used in operating activities

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment
Purchases of short-term investments
Maturities of short-term investments
Net cash used in investing activities

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from bridge loan (related party)
Proceeds from sale of Series A preferred stock
Issuance of common stock, pre-funded warrants and common stock warrants in April 2024 sale, net of issuance costs
Issuance of common stock upon June 2023 public offering, net of issuance costs
Issuance of common stock upon November 2023 public offering, net of issuance costs
Issuance of common stock, net of issuance costs
Issuance of common stock upon exercise of stock options
Net cash provided by financing activities
Net increase/(decrease) in cash and cash equivalents

Net increase/(decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest
NONCASH INVESTING AND FINANCING ACTIVITIES:
Accretion of Series A redeemable convertible preferred stock
Accretion of Series B redeemable convertible preferred stock
Conversion of preferred stock to common stock upon initial public offering
Reclassification of liability-classified warrants upon initial public offering
Issuance of underwriter warrants upon initial public offering
Issuance of convertible promissory notes for completion of non-employee services
Beneficial conversion feature upon issuance of convertible promissory note
Conversion of convertible promissory notes upon initial public offering
Vesting of common stock issued upon early exercise
Issuance of common stock for non-employee services
Reclassification of deferred offering costs upon initial public offering
[Property and equipment purchases in account payable]
Property and equipment purchases in other current liabilities
Right of use asset recorded for equipment finance lease
Warrants issued upon February 2023 public offering
Issuance of common stock warrant
Issuance of common stock warrants in April 2024 sale
Right of use asset recorded for operating lease liability
Original issue discount on bridge loan
Issuance costs on bridge loan (related party) recorded in accounts payable
Accrued interest on bridge loan (related party) in other current liabilities
Amortization of original issue discount on bridge loan (related party)
Costs (in equity) related to sale of Series A preferred stock recorded in accounts payable

Comments